SynthesisCardiovascular diabetology2011

Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes.

Robert Ratner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.